Skip to main content
. 2023 Oct 16;51(3):707–720. doi: 10.1007/s00259-023-06469-w

Fig. 3.

Fig. 3

CBF, arterial transit time delay and tissue mean transit time (MTT) maps are shown at rest and after infusion of acetazolamide (Diamox) for a patient suffering from Moya-Moya disease and left internal carotid artery stenosis. Acetazolamide decreases CBF in the affected hemisphere and increases regional arterial transit time delays and MTT. The CBF values are corrected for the regional arterial transit time delays